The critical roles of BDNF in MM pathophysiology are evidenced by its over-expression in malignant plasma cells and myeloma cell lines, as well as its potential ability to promote the growth of MM cells in vitro [20], [21]. This evidence concerns the gene BDNF and Miyoshi myopathy.